AdipoGen Life Sciences Notch signalling research reagents

Wednesday, 31 May, 2017 | Supplied by: Sapphire Bioscience

The Notch signalling pathway regulates many different cell fate decisions in both vertebrate and invertebrate species. Deregulations in Notch signalling components have been associated with various human disorders such as cancer, immune disorders, developmental syndromes, stroke and cognitive symptoms.

AdipoGen Life Sciences brings a comprehensive range of Notch signalling reagents to the market. Products include Notch receptors (Notch 1 and 2), canonical Notch ligands (DLL1, DLL3 and DLL4), non-classical Notch ligands (DLK1 and DLK2), E3 ubiquitin ligases, deubiquitinating enzymes and Notch inhibitors.

The reagents are suitable for scientists requiring tools for cancer, T cell and developmental biology research.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022

Content from other channels on our network

HSR and NIP labelling under review, FSANZ calls for information

Cargo airline joins coalition to reduce energy in frozen food supply chain

Kerry drives innovation to meet demand for lactose-free products

Maple syrup explored as a potential sugar substitute

ST. ALi doubles capacity with second coffee packaging machine

NSW celebrates recycling triumph

REMONDIS expands into Western Qld

From coal to clean: accelerating Asia's renewable energy transition

Experts call for fashion waste overhaul

Mitigating cybersecurity risks in tomorrow's smart cities

Major US defence company sets up in SA

TNA's industrial XR brings Industry 5.0 to food manufacturers

Queensland boosting local manufacturing

Hazer completes testing of its commercial demonstration plant

Anticipating maintenance problems with predictive analytics

AdipoGen Life Sciences Notch signalling research reagents

Lumiprobe DusQ fluorescence quenchers

Enzo Life Sciences SCREEN-WELL Epigenetics library

LSBio PathPlus Cancer Antibodies

Content from other channels on our network